News Categories
Latest News
Private payrolls rose by just 22,000 in January, far short of expectations, ADP says - CNBC
The U.S. labor market barely budged in January, with hiring below even muted expectations.
Eli Lilly Surges 9% After Obliterating Forecasts As Mounjaro, Zepbound Sales Double - Investor's Business Daily
While Novo Nordisk is calling for a sales downfall in 2026, Eli Lilly is more upbeat.
Wegovy maker warns of 'painful' price cuts as shares plunge - BBC
Novo Nordisk is facing “unprecedented” price pressures, “intensifying competition” and patents expiring.
Yum Brands posts mixed quarter, Taco Bell shines - CNBC
Taco Bell’s same-store sales spiked 7% in the quarter.
Eli Lilly blows past quarterly estimates, posts strong outlook as Zepbound and Mounjaro sales soar - CNBC
Eli Lilly’s full-year guidance comes in stark contrast to the outlook of Novo Nordisk, which warned it sees sales and profit declining as much as 13% this year.
The Fed is more divided than ever. Enter Kevin Warsh. - Politico
If Warsh wants to “deliver significantly lower rates, he’ll need to get the votes,” said Bill English, who formerly led the Fed’s monetary affairs division.